ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE000NITTFF2
Stock Name / FundiShares Russell 1000 Growth UCITS ETF
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerR1GR(USD) AS
ETF TickerR1GR(USD) Euronext Amsterdam

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares Russell 1000 Growth UCITS ETF LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-12-02 (Tuesday)12,712USD 13,298,277LLY holding decreased by -149621USD 13,298,2770USD -149,621 USD 1046.12 USD 1057.89
2025-12-01 (Monday)12,712USD 13,447,898LLY holding decreased by -223477USD 13,447,8980USD -223,477 USD 1057.89 USD 1075.47
2025-11-28 (Friday)12,712USD 13,671,375LLY holding decreased by -366995USD 13,671,3750USD -366,995 USD 1075.47 USD 1104.34
2025-11-27 (Thursday)12,712USD 14,038,370USD 14,038,3700USD 0 USD 1104.34 USD 1104.34
2025-11-26 (Wednesday)12,712USD 14,038,370LLY holding decreased by -71187USD 14,038,3700USD -71,187 USD 1104.34 USD 1109.94
2025-11-25 (Tuesday)12,712USD 14,109,557LLY holding increased by 505683USD 14,109,5570USD 505,683 USD 1109.94 USD 1070.16
2025-11-24 (Monday)12,712USD 13,603,874LLY holding increased by 132968USD 13,603,8740USD 132,968 USD 1070.16 USD 1059.7
2025-11-21 (Friday)12,712LLY holding increased by 108USD 13,470,906LLY holding increased by 321279USD 13,470,906108USD 321,279 USD 1059.7 USD 1043.29
2025-11-20 (Thursday)12,604USD 13,149,627LLY holding decreased by -79531USD 13,149,6270USD -79,531 USD 1043.29 USD 1049.6
2025-11-19 (Wednesday)12,604USD 13,229,158LLY holding increased by 246408USD 13,229,1580USD 246,408 USD 1049.6 USD 1030.05
2025-11-18 (Tuesday)12,604USD 12,982,750LLY holding increased by 105243USD 12,982,7500USD 105,243 USD 1030.05 USD 1021.7
2025-11-17 (Monday)12,604USD 12,877,507LLY holding decreased by -45122USD 12,877,5070USD -45,122 USD 1021.7 USD 1025.28
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE000NITTFF2

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-21BUY1081,066.6501,038.000 1,040.865EUR 112,413 813.91
2025-11-05SELL-108955.410908.230 912.948EUR -98,598 802.58 Loss of -11,920 on sale
2025-11-04BUY108915.220883.640 886.798EUR 95,774 802.03
2025-11-03BUY108901.339862.680 866.546EUR 93,587 801.54
2025-10-30BUY108853.000812.250 816.325EUR 88,163 800.99
2025-09-30BUY108763.000766.350 766.015EUR 82,730 799.71
2025-09-24SELL-39741.850746.940 746.431EUR -29,111 801.43 Profit of 2,145 on sale
2025-08-20BUY107705.440705.800 705.764EUR 75,517 805.98
2025-08-18BUY321698.050707.750 706.780EUR 226,876 807.34
2025-07-18BUY107771.710775.960 775.535EUR 82,982 807.87
2025-07-09SELL-214786.920794.000 793.292EUR -169,764 808.80 Profit of 3,319 on sale
2025-07-08BUY214777.660792.690 791.187EUR 169,314 809.01
2025-07-02BUY428779.280779.840 779.784EUR 333,748 809.87
2025-06-04BUY404765.840772.620 771.942EUR 311,865 813.14
2025-05-21BUY808724.950750.520 747.963EUR 604,354 820.62
2025-05-01BUY101794.100850.930 845.247EUR 85,370 828.56
2025-04-22BUY303827.540832.000 831.554EUR 251,961 825.77
2025-04-16BUY1,212734.900756.300 754.160EUR 914,042 826.55
2025-04-14BUY101754.350759.560 759.039EUR 76,663 828.16
2025-04-10BUY101720.910741.950 739.846EUR 74,724 830.52
2025-04-07SELL-303723.730748.000 745.573EUR -225,909 833.98 Profit of 26,789 on sale
2025-03-31BUY101825.910828.010 827.800EUR 83,608 835.86
2025-03-27BUY505821.670826.770 826.260EUR 417,261 836.22
2025-03-21SELL-36837.570850.430 849.144EUR -30,569 835.72 Loss of -483 on sale
2025-03-19BUY102837.010842.130 841.618EUR 85,845 835.60
2025-03-18BUY102822.510836.290 834.912EUR 85,161 835.79
2025-02-27BUY102905.160925.500 923.466EUR 94,194 829.72
2025-02-25SELL-102901.800912.000 910.980EUR -92,920 826.91 Loss of -8,575 on sale
2025-02-24SELL-102881.400893.110 891.939EUR -90,978 825.92 Loss of -6,734 on sale
2025-02-06BUY102870.370887.740 886.003EUR 90,372 814.85
2025-02-05BUY102842.180846.900 846.428EUR 86,336 814.20
2024-12-10BUY101799.580814.000 812.558EUR 82,068 817.40
2024-12-09BUY101803.580823.700 821.688EUR 82,990 817.85
2024-12-02SELL-101799.800805.350 804.795EUR -81,284 817.61 Profit of 1,295 on sale
2024-11-25BUY101755.000755.000 755.000EUR 76,255 825.81
2024-11-08BUY303831.540847.270 845.697EUR 256,246 855.95
2024-11-06BUY101776.380820.730 816.295EUR 82,446 867.45
2024-10-30BUY101846.830860.500 859.133EUR 86,772 900.25
2024-10-22SELL-1,818909.150911.120 910.923EUR -1,656,058 906.13 Loss of -8,714 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy